Related Experiment Video
Updated: Aug 10, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Specific and non-specific responses in host resistance to tumors
Abstract:
Host recognition of tumor associated antigens can be manipulated so as to produce rejection of tumor cells. This manipulation is dependent upon the tumor expressing appropriate levels of tumor antigen and whilst active specific immunotherapy may be effective against tumors induced with extrinsic agents (carcinogens, oncogenic viruses) few naturally arising rodent tumors respond to therapy. Sensitized T lymphocytes are involved in specific tumor immune responses and in many cases these effector cells are tumoricidal. With other rodent tumors, however, cytotoxic T cells may not be effective and in this case the specific response may lead to activation/augmentation of non-specific immunity mediated by activated macrophage and/or natural killer cells.
Insights
Tumor immunotherapy shows promise by manipulating host recognition of tumor antigens. However, naturally occurring tumors often resist treatment, requiring alternative immune strategies like macrophage and natural killer cell activation.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Host immune recognition of tumor-associated antigens can be harnessed for cancer rejection.
- Effective cancer immunotherapy relies on appropriate tumor antigen expression levels.
- Naturally arising tumors in rodents often exhibit resistance to active specific immunotherapy.
Purpose of the Study:
- To investigate the mechanisms of tumor rejection through host immune manipulation.
- To explore the efficacy of immunotherapy against naturally occurring rodent tumors.
- To understand the role of T lymphocytes and alternative immune cells in tumor response.
Main Methods:
- Analysis of tumor antigen expression levels.
- Evaluation of active specific immunotherapy in rodent tumor models.
- Assessment of T lymphocyte responses and their tumoricidal activity.
- Investigation of non-specific immunity mediated by macrophages and natural killer cells.
Main Results:
- Tumor rejection is achievable by manipulating host recognition of tumor antigens.
- Active specific immunotherapy is effective against tumors induced by extrinsic agents.
- Naturally arising rodent tumors show limited response to current immunotherapy approaches.
- Cytotoxic T cells are not always effective, necessitating alternative immune activation.
Conclusions:
- Successful tumor rejection depends on host immune system manipulation and tumor antigen presentation.
- While T lymphocytes are key, alternative immune pathways involving activated macrophages and natural killer cells are crucial for combating resistant tumors.
- Future cancer immunotherapy strategies may need to incorporate augmentation of non-specific immunity for broader efficacy.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
Related Concept Videos
Cell-mediated Immune Responses
The Tumor Microenvironment
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy